Ravit Boger

Ravit Boger, MD, is a Professor and Chief in the Department of Pediatrics Infectious Disease at the Medical College of Wisconsin. Her research focuses on human cytomegalovirus (HCMV), antiviral drug development, and viral pathogenesis, with a particular emphasis on pediatric and immunocompromised populations. She explores novel therapies targeting HCMV using compounds like cardiac glycosides, artemisinin derivatives, and synthetic ozonides. Her work bridges basic science and clinical applications, addressing urgent needs in congenital infections and transplant recipient care.

Key research themes include HCMV inhibition mechanisms, immune evasion pathways, and translational strategies for neuroprotection and antiviral efficacy. Dr. Boger has contributed to advanced models using neural progenitor cells and humanized mice to study viral dynamics. Her studies often involve collaborations across immunology, pharmacology, and genomics to uncover molecular targets and biomarkers for precision medicine.

Recent publications highlight interspecies differences in drug efficacy, mitophagy-regulated immune responses, and genomic predictors of HCMV DNAemia in kidney transplant patients. Her work underscores the importance of repurposing existing drugs and developing multiplexed diagnostic tools to improve clinical outcomes in viral infections.